Attending the BIO CEO & Investor Conference at the New York: February 6-9, 2023?Learn how pharmaceutical companies can accelerate drug discovery and advance drug development by pairing Predictive Oncology’s artificial intelligence of its PEDAL platform with features derived from the company’s extensive biobank of 150K+ tumor samples. Potential investors and partners are invited to meet with CEO Raymond F. Vennare and CBO Dr. Pamela Bush. Please email partner@predictive-oncology.com.
